Clinical trials sponsored by Abbisko Therapeutics Co, Ltd

Phase breakdown

Conditions studied

Recruiting trials led by Abbisko Therapeutics Co, Ltd

• A Phase 2 Clinical Study of ABSK061 and ABSK043
  NCT06632262 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 21 locations
• A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Glecirasib
  NCT07164170 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 17 locations
• A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic Cancer
  NCT06111274 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 5 locations
• A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK112 in Patients With Non-Small Cell Lung Cancer
  NCT06225804 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 14 locations

Common questions

How many trials is Abbisko Therapeutics Co, Ltd recruiting for?

Abbisko Therapeutics Co, Ltd is the lead sponsor of 4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.